Charles Bennett to Drug Industry
This is a "connection" page, showing publications Charles Bennett has written about Drug Industry.
Connection Strength
4.970
-
Policing of Drug Safety Information Dissemination Under the False Claims Act. Cancer Treat Res. 2022; 184:53-59.
Score: 0.738
-
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
Score: 0.607
-
Biosimilars-Curb Your Enthusiasm. JAMA Oncol. 2017 11 01; 3(11):1467-1468.
Score: 0.553
-
Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door. J Clin Oncol. 2016 12 20; 34(36):4320-4322.
Score: 0.516
-
Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment. JAMA Oncol. 2016 Feb; 2(2):274-6.
Score: 0.490
-
Pharmaceutical fraud and abuse in the United States, 1996-2010. Arch Intern Med. 2011 Sep 12; 171(16):1503-6.
Score: 0.361
-
Enforcement actions involving Medicaid fraud and abuse, 1996-2009. Arch Intern Med. 2011 Apr 25; 171(8):785-7.
Score: 0.352
-
Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents. Arch Intern Med. 2010 Sep 13; 170(16):1490-8.
Score: 0.337
-
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. 2007 May 28; 167(10):1041-9.
Score: 0.268
-
Humira: the first $20 billion drug. Am J Manag Care. 2023 02; 29(2):78-80.
Score: 0.199
-
Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA. 1999 Oct 20; 282(15):1453-7.
Score: 0.158
-
Why California's Proposition 61 Was a Bad Idea. Am J Med. 2017 08; 130(8):882-884.
Score: 0.133
-
Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells. JAMA Oncol. 2016 Jan; 2(1):134-6.
Score: 0.122
-
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract. 2012 Nov; 8(6):e158-67.
Score: 0.096
-
Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials. J Clin Oncol. 1995 Sep; 13(9):2457-63.
Score: 0.030
-
The uncertainty principle and industry-sponsored research. Lancet. 2000 Aug 19; 356(9230):635-8.
Score: 0.010